(ALNY) - Analyzing Alnylam Pharmaceuticals's Short Interest
Portfolio Pulse from Benzinga Insights
Alnylam Pharmaceuticals (NYSE:ALNY) has seen a 7.43% increase in its short percent of float, now at 4.34% with 4.84 million shares sold short. This indicates a bearish sentiment among investors, although its short interest is below the peer group average of 5.14%.
October 31, 2024 | 7:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Alnylam Pharmaceuticals has experienced a 7.43% increase in short interest, now at 4.34% of float. This suggests a bearish sentiment, but its short interest is still below the peer average of 5.14%.
The increase in short interest indicates a bearish sentiment among investors, which could lead to downward pressure on the stock price. However, the short interest is still below the peer average, which might mitigate some of the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100